These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 14640395

  • 1. Highly active antiretroviral therapy: physician experience and enhanced adherence to prescription refill.
    Delgado J, Heath KV, Yip B, Marion S, Alfonso V, Montaner JS, O'Shaughnessy MV, Hogg RS.
    Antivir Ther; 2003 Oct; 8(5):471-8. PubMed ID: 14640395
    [Abstract] [Full Text] [Related]

  • 2. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A, Tyndall MW, Chan K, Wood E, Montaner JS, Hogg RS.
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [Abstract] [Full Text] [Related]

  • 3. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T, Palepu A, Barness G, Walsh J, Hogg R, Montaner J, Tyndall M, Wood E.
    Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
    [Abstract] [Full Text] [Related]

  • 4. Association between pharmacy medication refill-based adherence rates and cd4 count and viral-load responses: A retrospective analysis in treatment-experienced adults with HIV.
    Townsend ML, Jackson GL, Smith R, Wilson KH.
    Clin Ther; 2007 Apr; 29(4):711-6. PubMed ID: 17617294
    [Abstract] [Full Text] [Related]

  • 5. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV.
    Grossberg R, Zhang Y, Gross R.
    J Clin Epidemiol; 2004 Oct; 57(10):1107-10. PubMed ID: 15528063
    [Abstract] [Full Text] [Related]

  • 6. Regimen-dependent variations in adherence to therapy and virological suppression in patients initiating protease inhibitor-based highly active antiretroviral therapy.
    Moore DM, Hogg RS, Yip B, Wood E, Harris M, Montaner JS.
    HIV Med; 2006 Jul; 7(5):311-6. PubMed ID: 16945076
    [Abstract] [Full Text] [Related]

  • 7. Adherence to antiretroviral therapy and CD4 T-cell count responses among HIV-infected injection drug users.
    Wood E, Montaner JS, Yip B, Tyndall MW, Schechter MT, O'Shaughnessy MV, Hogg RS.
    Antivir Ther; 2004 Apr; 9(2):229-35. PubMed ID: 15134185
    [Abstract] [Full Text] [Related]

  • 8. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
    Palepu A, Tyndall MW, Joy R, Kerr T, Wood E, Press N, Hogg RS, Montaner JS.
    Drug Alcohol Depend; 2006 Sep 15; 84(2):188-94. PubMed ID: 16542797
    [Abstract] [Full Text] [Related]

  • 9. Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Côte d'Ivoire.
    Diabaté S, Alary M, Koffi CK.
    AIDS; 2007 Aug 20; 21(13):1799-803. PubMed ID: 17690579
    [Abstract] [Full Text] [Related]

  • 10. Validity of self-reported adherence among injection drug users.
    Kerr T, Hogg RS, Yip B, Tyndall MW, Montaner J, Wood E.
    J Int Assoc Physicians AIDS Care (Chic); 2008 Aug 20; 7(4):157-9. PubMed ID: 18626123
    [Abstract] [Full Text] [Related]

  • 11. Highly active antiretroviral therapy adherence and its determinants in selected hospitals from south and central Ethiopia.
    Beyene KA, Gedif T, Gebre-Mariam T, Engidawork E.
    Pharmacoepidemiol Drug Saf; 2009 Nov 20; 18(11):1007-15. PubMed ID: 19650153
    [Abstract] [Full Text] [Related]

  • 12. Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women.
    Kapadia F, Vlahov D, Wu Y, Cohen MH, Greenblatt RM, Howard AA, Cook JA, Goparaju L, Golub E, Richardson J, Wilson TE.
    Am J Drug Alcohol Abuse; 2008 Nov 20; 34(2):161-70. PubMed ID: 18293232
    [Abstract] [Full Text] [Related]

  • 13. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
    Bouhnik AD, Préau M, Vincent E, Carrieri MP, Gallais H, Lepeu G, Gastaut JA, Moatti JP, Spire B, MANIF 2000 Study Group.
    Antivir Ther; 2005 Nov 20; 10(1):53-61. PubMed ID: 15751763
    [Abstract] [Full Text] [Related]

  • 14. Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.
    Protopopescu C, Raffi F, Roux P, Reynes J, Dellamonica P, Spire B, Leport C, Carrieri MP, ANRS CO8 APROCO-COPILOTE Study Group.
    J Antimicrob Chemother; 2009 Sep 20; 64(3):599-606. PubMed ID: 19602563
    [Abstract] [Full Text] [Related]

  • 15. Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy.
    Lima VD, Hogg RS, Harrigan PR, Moore D, Yip B, Wood E, Montaner JS.
    AIDS; 2007 Mar 30; 21(6):685-92. PubMed ID: 17413689
    [Abstract] [Full Text] [Related]

  • 16. Medication refill logistics and refill adherence in HIV.
    Gross R, Zhang Y, Grossberg R.
    Pharmacoepidemiol Drug Saf; 2005 Nov 30; 14(11):789-93. PubMed ID: 15880515
    [Abstract] [Full Text] [Related]

  • 17. Effect of patient adherence to antiretroviral therapy on the progression of cervical dysplasia among HIV-infected women.
    Bernal A, Walters ST, Paulson RM, Mubasher M.
    AIDS Read; 2008 Jul 30; 18(7):382-5. PubMed ID: 18655315
    [Abstract] [Full Text] [Related]

  • 18. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.
    Lima VD, Harrigan R, Murray M, Moore DM, Wood E, Hogg RS, Montaner JS.
    AIDS; 2008 Nov 12; 22(17):2371-80. PubMed ID: 18981777
    [Abstract] [Full Text] [Related]

  • 19. HIV-infected pregnant women have greater adherence with antiretroviral drugs than non-pregnant women.
    Vaz MJ, Barros SM, Palacios R, Senise JF, Lunardi L, Amed AM, Castelo A.
    Int J STD AIDS; 2007 Jan 12; 18(1):28-32. PubMed ID: 17326859
    [Abstract] [Full Text] [Related]

  • 20. Heterogeneity of physician agreement with recommended therapeutic guidelines for the management of HIV-associated disease.
    Montaner JS, Hogg RS, Heath KV, Phillips P, Craib KJ, Schechter MT, O'Shaughnessy MV.
    Antivir Ther; 1996 Aug 12; 1(3):157-66. PubMed ID: 11322249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.